FDA approves cervical disk device

July 17, 2007

The U.S. Food and Drug Administration Tuesday announced approval of the first device designed to treat cervical degenerative disc disease.

The Prestige Cervical Disc, manufactured by Medtronic Sofamor Danek of Memphis, is used to treat one of the most common causes of neck and arm pain.

"The approval of this artificial disc means that people with cervical degenerative disc disease now will have another surgical option for treating this condition," said Dr. Daniel Schultz, director of the FDA's Center for Devices and Radiological Health. "This device will help relieve pain and restore function."

The FDA said current surgical treatments involve removing a diseased or bulging disc in a patient's neck and fusing two or more bony vertebrae. The Prestige Cervical Disc allows the option of replacing the impaired natural disc.

The FDA said it based its approval on the company's laboratory and animal testing, and on its clinical study of 541 patients.

As a condition of approval, the company will conduct a post-approval study during the next seven years to evaluate the longer term safety and effectiveness of the device.

The Prestige Cervical Disc was approved as a class III, or high-risk, device.

Copyright 2007 by United Press International

Explore further: Neurosurgeons use adult stem cells to grow neck vertebrae

Related Stories

Neurosurgeons use adult stem cells to grow neck vertebrae

September 6, 2011

Neurosurgery researchers at UC Davis Health System have used a new, leading-edge stem cell therapy to promote the growth of bone tissue following the removal of cervical discs -- the cushions between the bones in the neck ...

UCSF analysis shows newer surgery for neck pain may be better

April 11, 2011

A new surgery for cervical disc disease in the neck may restore range of motion and reduce repeat surgeries in some younger patients, according to a team of neurosurgeons from the University of California, San Francisco (UCSF) ...

Recommended for you

Study shows blood products unaffected by drone trips

December 7, 2016

In what is believed to be the first proof-of-concept study of its kind, Johns Hopkins researchers have determined that large bags of blood products, such as those transfused into patients every day, can maintain temperature ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.